Silver Book Fact

Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.

Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer. Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells. Proceedings of the National Academy of Sciences. 2004; 101(34): 12543-8. http://www.pnas.org/cgi/content/short/101/34/12543

Reference

Title
Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells
Publication
Proceedings of the National Academy of Sciences
Publication Date
2004
Authors
Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer
Volume & Issue
Volume 101, Issue 34
Pages
12543-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • New Medicines in Development for Parkinson’s Disease in 2018
     
  • Stopping the Progress of Parkinson’s Would Save >$440,000 per Person
     
  • Research breakthroughs that slow the onset and progression of Alzheimer’s disease could achieve annual Medicare savings of $51 billion by 2015, $126 billion by 2025, and $444 billion by 2050.  
  • In one study, Alzheimer’s patients who took donepezil had an increase in their prescription costs of $1,000 per patient, but saw reduced total medical costs of about 1/3–from $11,947 to…  
  • Slowing the progression of Parkinson’s disease by just 10% would save $327 million (in direct and indirect costs) to the U.S. annually.